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ABSTRACT
￿
We have previously reported a decreased activity of the lysosomal enzyme dipep-
tidyl aminopeptidase-I (DAP-1) in cultured fibroblasts from patients with Duchenne's muscular
dystrophy (DMD). Here we report that electron microscope examination of these cells reveals
the presence of abundant lamellar bodies, a morphologic abnormality commonly associated
with impaired lysosomal function . Morphometric analysis of these cytoplasmic figures in
dystrophic cells shows a sevenfold increase relative to normal controls (P < 0.01) . Analysis of
lysosomal density profiles by density gradient centrifugation reveals similar patterns in normal
and DMD cells. Treatment of lysosomes with the nonionic detergent Triton X-100 causes an
activation of DAP-I. This activation, attributable to structure-linked latency, is markedly
diminished in DMD cells which show an optimal activation of only 180% compared to 255%
for control fibroblasts (P < 0.01) . These data suggest an alteration in the properties of the
lysosomal membrane in DMD fibroblasts. This suggestion is also supported by studies on the
release of DAP-1 from lysosomes by osmotic shock which show it to be a membrane-associated
enzyme with membrane-binding characteristics intermediate between those of tightly bound
,ß-glucosidase and those of unbound N-acetylgalactosaminidase. The latency characteristics of
these other lysosomal enzymes are not altered in the DMD cells, indicating that the effect is
specific for DAP-I.
Studies of the biochemical etiology of Duchenne's muscular
dystrophy (DMD) are complicated by the presence in the
diseased muscle tissue of a variety of nonspecific degenerative
changeswhichserve to obscuretheprimaryerrorofmetabolism
(2). To avoid this difficulty, investigations of the properties of
certain nonmuscle tissues in these patients have been under-
taken. In erythrocytes, phosphorylation of membrane proteins
(2) and the activities of the membrane enzymes adenylate
cyclase and (Na' + K+)ATPase have been reported to be
altered in DMD (19, 20), and in lymphocytes a defect in
capping has also been reported (23), although many of these
changesremain to be confirmed. Asmall number ofstudies on
the properties of cultured skin fibroblasts from DMD patients
have also appeared. Pena et al. (22) have reported that the
growth and longevity in culture of these cells are normal,
suggesting that study of cultured DMD fibroblasts is not com-
plicated by the presence of extensive degenerative changes.
Wyattand Cox (33) have reported that cultured skin fibroblasts
from their DMD patients contain numerous dense inclusion
bodies visible in the electron microscope, whereas these bodies
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are rarely seen in control cells. Subsequently, Cullen and
Parsons (5) reported that they were unable to confirm the
presence ofexcessive amountsofinclusionbodies in theirseries
of fibroblasts from a different set of DMD patients. Ionasescu
et al. (11) reported that collagen metabolism was altered in
fibroblast cultures from DMD patients, but Stevens et al. (31)
have since reported that this parameter wasunchangedin their
cultured DMD fibroblasts.
We have recently reported that the activity of the lysosomal
enzyme dipeptidyl aminopeptidase I(DAP-1) was significantly
decreased in DMD cultured skin fibroblasts (8). It was also
shown that this decrease in DAP-I activity probably represents
a regulatory change in which fewer active DAP-I molecules
are present in the DMD cells rather than a change in the
structure or catalytic efficiency of the individual enzyme mol-
ecules. We have now extended our investigation of the lyso-
somal characteristics of cultured skin fibroblasts from DMD
patients by examining the gross and ultrastructural morphol-
ogy, lysosomal density profiles, and structure-linked latencies
of various lysosomal enzymes. The results of these studies
329reported here reveal that there are significant differences in
some of theseparameters which collectively point to a possible
alteration of the lysosomal membrane in DMD fibroblasts.
MATERIALS AND METHODS
Cells
Eight lines of fibroblasts from DMD patients and six age- and sex-matched
normal controls were obtained as described previously (8). Briefly, six of the
DMD lines and four of the control lines were obtained from the Repository for
Mutant Human Cell Strains (Montreal, Canada). Twoof the control lines were
obtained from the Institute for Medical Research (Camden, N. J.), and two of
the DMD lines were developed in our laboratory from skin biopsies obtained
from patients at the Neurology Clinic of the University of Cincinnati Medical
Center. Themaintenance procedures for these cells are described elsewhere (8).
All studies were performed on confluent cell cultures, and the passage number
forallcell lines was t2 in anygiven experiment. Cells were used between passage
numbers 5 and 30, which is well before the onset of stage lI growth in these cell
lines.
Enzyme Assays and Lysosome Preparation
,8-glucosidase (EC 3.2.1.21), N-acetylgalactosaminidase (EC 3.2.1.49), and
dipeptidyl aminopeptidase I (EC 3.4.14.1) were assayed fluorometrically as
previously described (8). Cells were prepared for enzymatic studies by first
washing them on the culture dish twice with ice-cold 0.25 M sucrose and then
harvesting with a rubber policeman into 3.0 ml of ice-cold 0.25 Msucrose. Cells
were passed 20times through a Kontes no. 23 Teflon-glass tissue grinder (Kontes
Glass Co., Vineland, N. J.) with the pestle rotating at 200 rpm. Thehomogenate
was centrifuged at 750 g for 10 min at 4°C, and the postnuclear supernate was
centrifuged at 30,000gfor 20 min at 4°C to obtain a crude lysosomal pellet. The
supernate was discarded and the crude lysosomal pellet was resuspended in 10
ml of ice-cold 0.25 M sucrose, recentrifuged at 30,000 g for 20 min at 4°C, and
this washed pellet was finally resuspended in 2-4 ml of ice-cold 0.25 M sucrose.
Protein concentration was assayed by the procedure of Lowry et al. (15), with
bovine serum albumin serving as standards.
Acridine Orange Uptake
Cultured fibroblasts from normal and DMD patients were incubated with
acridine orange (Eastman Kodak Co., Rochester, N. Y.) by the procedure of
Allison and Young (1). The cells were then viewed in a Zeiss fluorescence
microscope and photographedwith Kodak high-speedektachrome film. The film
was pushed in development to give an ASA rating of 1600: this is necessary to
prevent excessive bleaching ofthe dye molecules during the exposure. Thesame
incubation technique (1) was used to quantitate the amount of fluorescence in
whole cells by harvesting the cells withtrypsin, exposing themto acridine orange,
and measuring the fluorescence at 490 (excitation) and 530 nm (emission) in a
Perkin-Elmerspectrofluorimeter (Perkin-ElmerCorp., Instrument Div.,Norwalk,
Conn.). The ability of a crude 30,000 glysosomal pellet prepared as described
above to take up acridine orange was measured by the method of Dell'Antone
(6).
Ultrastructural Studies
Cultured human fibroblasts were prepared for electron microscopy in situ
according to the method ofMorris et al. (21). Briefly, 100-mm plastic petri dishes
(Falcon Labware, Div. Becton, Dickinson & Co., Oxnard, Calif.) containing
slightly subconfluent monolayers were washed three times with cold phosphate-
buffered saline (PBS), pH 7.4. After a briefincubation in an ice bath, 10 ml of a
"fixative" containing 1 .3% OSO< and 4.2% glutaraldehyde in PBSwas added and
eachdish was incubated at 4°C. After a90-min fixation period, each sample was
washed twice with cold PBS, washed twice additionally with 0.15 M sodium
chloride, and postfixed with 0.5% uranyl acetate in 70% ethanol for 30 min at
23°C. The postfixative solution was decanted and tissue dehydration was com-
pleted by three subsequent 10-min washes with absolute ethanol. Samples were
infiltrated and embedded in Epon 812 (Ernest F. Fullam, Inc., Schenectady, N.
Y.) according to the method of Luft (17). The resin was polymerized by an
overnight incubation at 40°C followed by 72-h incubation at 80°C. All samples
were allowed to remain at 23°C for 24 h, after which the resin containing the
intact monolayerwas easilyseparated from the plastic culture dish by peeling the
two surfaces apart. Samples were examined microscopically and those areas
showing the greatest cell densities were marked and punched out with an electric
cork borer. Specimens measuring 0.5 cm indiameter were mounted and sectioned
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on a Reichert OM-U3 ultramicrotome with a diamond knife. Sections were
viewed unstained with a JEOL-10011 electron microscope operating at 60 kV.
Statistics
Thestatistical comparisons were based on the two-tailed Student's t test (25).
Thelevel of significance chosen was P<0.05.
RESULTS
Gross and Ultrastructural Lysosomal Morphology
Ultrastructuralexamination of numerous profiles of normal
human fibroblasts revealed a characteristic spindle shape. The
mitochondria were extremely long and thin, the Golgi com-
plexes consisted of flattened vesicles aligned along the long
axis of the cell in the perinuclear region, and bundles of
microtubules and microfilaments were seen running under the
cell surface. These observations are consistent with those re-
ported by Luckyet al. (16). Examinationofdystrophic human
fibroblasts revealed the same ultrastructural organization ex-
cept that there was also a pronounced presence of lamellar
bodies. These lamellar bodies or "myelin figures" consist of
membrane-bounded cytoplasmic vesicles containing a series of
concentric, membranelike swirls (Figs. 1and2).Themembrane
surrounding the lamellar body was sometimes found to be
discontinuous or disrupted. We do not know the significance
of this observation. It was notuncommon to view two or more
series of membranous swirls within a single vesicle. Also,
frequently viewed within themembrane ofalamellar body was
an amorphous, electron-dense substance (Fig. 1). In general,
the subcellular location ofthelamellar bodies wasrestricted to
the area immediately adjacent to the nucleus.
Subsequent morphometric studies were initiated to deter-
mine whether the above observation of an increased number
of lamellar bodies in DMD cells was statistically significant.
Accordingly, six dystrophic and five normal human fibroblast
cell lines were evaluated for the number of lamellar bodies. To
avoid ambiguity and to make the study statistically relevant,
the following criteria were imposed. First, allcells were viewed
randomly: that is, each single grid was viewed until a cell
meeting the requirements outlined below was encountered.
Once a cell had been scored on a grid, no further cells on that
particular grid were scored. Second, a defined area of 7 x 9
cm was viewed at x 20,000. A magnification of 20,000 was
chosen for two reasons: (a) the smallest of the lamellar bodies
was easily discernible at this magnification, and (b) the area
circumscribed typically contained the majority of the lamellar
bodies. Third, only the cytoplasmic area immediately adjacent
to thenucleus(perinuclear region)was viewed. This reflects an
earlier observation that lamellar bodies were generally viewed
only in the perinuclear region. In addition to these require-
ments, allprospective cells had to fulfill the following require-
ments indicative of good fixation: (a) intact and contiguous
plasma membrane, (b) finely granular cytoplasmic ground
substance showingno empty spaces, (c) mitochondria showing
no signsofdistortion, and(d) nucleus present showingno signs
of pyknosis.
Using the above criteria, we scored both normal and dys-
trophic cells for the number of lamellar bodies. Table I shows
the results of this study. The average (mean ± SEM) number
of lamellar bodies per dystrophic cell was 7.5 t 2.8, whereas
with normal cellsonly 1.0 t 0.6 lamellar bodies/cell were seen.
This difference is significant at the P < 0.01 level. Lamellar
bodies were observed in 84% of all dystrophic cells analyzed,FIGURE 1
￿
Electron micrographs of cultured human fibroblasts . (A) Cell line MCH 20 : normal fibroblast with a small section of
nuclear membrane visible at upper left. Dark body at upper center is a centriole . Bar, 500 nm . (8) Cell lineWG 280 : DMD fibroblast
showing several lamellar bodies and swollen cisternae . Bar, 500 nm .
while only 43% of the normal counterparts possessed similar
organelles.
Multiple cells were examined for each cell line, and almost
without exception the dystrophic cells possessed more lamellar
bodies . The sole exception was cell line GM497 which, al-
though it is a normal control tine, possessed a number of
myelin figures approaching that of dystrophic cells (Table 1) .
The reason for this high value in GM497 cells is not known .
Since lamellar body formation is not infrequently associated
with other lysosomal abnormalities, we further examined the
lysosomal morphology of the cells at the light microscope level .
For these studies the lysosomes were viewed by fluorescence
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Electron micrographs of representative DMD cells . (A) Cell line WG 280 : DMD fibroblast showing two characteristic
lamellar bodies . Note the occurrence of the lamellar body enclosed within a disrupted membrane (arrows) . Bar, 500 nm . (B)
Higher magnification of a typical lamellar body viewed in the perinuclear region of cell line WG 448DMD fibroblast . Bar, 500 nm .
(C) High magnification of two lamellar bodies seen within the cytosol of cell line WG 348DMD fibroblast . Note that in the lower
lamellar body the surrounding membrane is noncontiguous . Bar, 500 nm .
microscopy after exposure of the cells to acridine orange . This
membrane-permeable, fluorescent dye is concentrated in lyso-
somes as a result of protonation of the dye at the low internal
pH of the lysosomal lumen which decreases the membrane
permeability of the dye molecule (29) . As the dye becomes
more concentrated there is a shift in the emission spectrum
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from green to orange so that the lysosomes are easily distin-
guished in the fluorescence microscope as bright, punctate,
orange inclusions on a green cytoplasmic background . Using
this technique, we saw that the subcellular localization of
lysosomes of both normal andDMD cells was primarily in the
perinuclear region . No difference in the average number, size,fluorescence intensity, or distribution of normal and DMD
acridine orange particles was observed in micrographs sub-
jected to double-blind evaluation.
Particle Density Studies
Rome et al. (26) recently described a procedure for separat-
ing two species of lysosomal organelles in cultured human
fibroblasts. These particles were resolved on self-generating,
colloidal silica-polyvinylpyrrolidone density gradients,yielding
a dense peak oflysosomal enzyme activity which, according to
the authors, is free of contamination with other organelles, and
a more buoyant peak which sedimented with several other
organelles. It has been postulated that the dense peak is derived
primarily from the residual bodies and the buoyant one from
fragmented pieces of the Golgi-endoplasmic reticulum-lyso-
some (GERL) network (26). To determine whether the enzy-
matic and morphological changes we have observed in DMD
cells are associated with an alteration in either of these lyso-
somal subclasses, we studied the density characteristics of
DMD and normal fibroblast lysosomes by this procedure. We
found that the components of the colloidal silica-polyvinylpyr-
rolidone gradient interfere with the assay procedure for DAP-
I, so the density distribution of this enzyme could not be
accurately determined. The distribution of two other lysosomal
enzymes from postnuclear supernates of six normal and six
DMD fibroblastlinesseparated on these self-generating density
gradients is shown in Fig. 3. The results are in agreement with
Rome et al. in that two distinct populations of lysosomal
particles having differing density characteristics were resolved
in both normal and DMD cells, in addition to the enzyme
activity associated with the nonsedimented overlay fractions.
The data show that the amount of enzyme activity appearing
in the soluble overlay peak varies, depending on the particular
lysosomal enzyme studied. Thus, the majority of,8-glucuroni-
dase activity appears in the nonsedimented peak, whereas #-
glucosidase, being firmly bound to the lysosomal particles (4),
appears mostly in the sedimented peaks of the gradient. (The
iß-glucosidase activity remaining in the overlay is probably
microvesiculated rather than trulysoluble, in view ofthe results
in Fig. 4 described below showing that the 30,000 g supernate
TABLE I
Occurrence of Lamellar Bodies in the Perinuclear Region of
Human Fibroblasts
P <0.01
5 10 15 20 25 30 35
Fraction no. (dense-light)
FIGURE 3
￿
Distribution of lysosomal enzyme activity on a self-gen-
erating colloidal silica-polyvinylpyrrolidone gradient for two differ-
ent enzymes. Peak at the lightest density represents soluble activity
remaining with the sucrose overlay, while the middle- and high-
density peaks represent the GERL and lysosome fractions, respec-
tively. Solid lines show average values for six different normal lines
measured as three sets of paired pools. Dotted lines show average
values for six different DMD lines, also measured as three sets of
paired pools.
displays some structure-linked latency ofis-glucosidase activity
after exposure to detergent.) Comparison of the normal and
DMD postnuclear supernate did not reveal qualitative changes
in the sedimentation pattern of lysosomal enzymes, as depicted
in Fig. 3. The morphological abnormalities described above in
the DMD cells do not, therefore, appear to be associated with
a significant change in the density characteristics of the two
populations of lysosomes resolved on these density gradients.
Thereis, however, a small but statistically significant difference
(P < 0.009) in the distribution ofthe peaks of /3-glucuronidase
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Designation Status
No. of
fields
viewed
No. of
fields
positive
No. of la-
mellar
bodies Avg. field
MCH 20 Normal 3 0 0 0.0
MCH 31 Normal 4 1 3 0.8
MCH 35 Normal 8 3 5 0.6
GM 2987 Normal 8 3 4 0.5
GM 497 Normal 12 8 38 3.2
Average Normal 1.0
W.G. 280 Dystrophic 12 8 39 3.3
W.G. 348 Dystrophic 6 5 20 3.3
W.G. 433 Dystrophic 5 5 106 21.2
W.G. 448 Dystrophic 4 4 17 4.3
W.G. 502 Dystrophic 13 11 103 7.9
A.B. 001 Dystrophic 3 3 14 4.7
Average Dystrophic 7 .5w
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FIGURE 4 Detergent activation of three lysosomal enzymes ex-
pressed as percent of activity in the absence of Triton X-100. Left-
hand panels show the effect of the detergent on enzyme activity in
isolated lysosomes, while the right-hand panels show the effect of
detergent on enzyme activity of soluble, nonparticulate enzyme
from disrupted lysosomes. Specific activity of DAP-I for both frac-
tions is also presented to show that the marked decrease in total
DMD DAP-1 activity previously reported (8) is also apparent under
these conditions. Thedata are given as mean ± SEM, n = 6 (normal,
shownin closed circles) or n =8 (dystrophic, shown in open circles) .
with less activity appearing in the DMD GERL fraction and
correspondingly more activity in the nonsedimenting overlay
peak. No other significant differences in lysosomal density
profiles were observed.
Enzyme Latency and Osmotic Sedimentation
Studies
The enzymes of isolated lysosomes are separated from ex-
ogenous substrate by the topologically closed membrane of the
lysosomal organelle. Consequently, these enzymes do not dis-
play maximal activity in intact lysosomes unless this membrane
barrier is compromised. The permeability barrier can be dis-
turbed by a number of procedures including hypotonic (os-
motic) stress, chemical disruption with detergents, or mechan-
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ical disruption such as sonication. The additional enzyme
activity that appears afterdisruption ofthe permeability barrier
is termed the latency of the enzyme. The extent of structure-
linked latency for a particularlysosomal enzyme depends upon
the characteristics of the permeability of the lysosomal mem-
brane to the substrate and cofactors for that enzyme. Latency
studies can thus be applied to studies of the general permea-
bility properties of the lysosomal membrane (24).
Structure-linked latency of three lysosomal enzymes was
examined using increasing concentrations of the detergent
Triton X-100 to disrupt the lysosomal membrane. The increase
in activity caused by the release of latent enzyme from the
lysosome is plotted in Fig. 4 as the percentage increase over
basal activity (100%~ observed in the absence of detergent. The
left-hand panels of Fig. 4 show that all three of these enzymes
were activated to the extent of -250% above basal (detergent-
free) activity, but that their sensitivity to enzyme inhibition by
Triton X-100 was markedly different. N-acetyl-galactosamini-
dase (GaINAcase) was not inhibited at any concentration of
detergent, and its latency curve therefore presents a mono-
phasic increase in activity which reaches a plateau at a concen-
tration of Triton X-100 corresponding to its critical micellar
concentration (CMC) (CMC = 0.017%, vol/vol). ß-Glucosi-
dase, on the other hand, displayed a marked inhibition by
Triton X-100 so that its latency curve is biphasic with activity
increasing up to the CMC and sharply declining thereafter.
DAP-I was less sensitive to inhibition by Triton X-100 and the
shape of its latency curve therefore appears as intermediate
between those of the above two enzymes, displaying a typical
rising phase followed by a more gradual inhibitory phase as
the CMC is exceeded. It should be emphasized that the rising
and falling phases ofthese detergent latency curves presumably
result from independent mechanisms. The rising "activation"
phase is the result of an interaction of the detergent with the
lysosomal membrane whereas the inhibitory phase results from
a more direct interaction between detergent and enzyme. To
examine the inhibitory effects of the detergent more closely,
we studied the effect ofTriton X-100 on sonicated preparations
containing only solubilized lysosomal enzymes, so as to elimi-
nate the effects of the activation phase of the curves. The
enzymes were released from the lysosomes by freeze-thaw (two
times) of a crude cell homogenate and the 30,000 g supernate
was used as solubilized enzyme. The results of these studies are
shown on the right-hand panels of Fig. 4. In the case of
GaINAcase, the latency phase of the curve was no longer
apparent as was expected and, as there had previously been no
inhibitory effect, the detergent therefore had no effect at all on
the activity of the solubilized enzyme. The results for 8-glu-
cosidase show that a significant degree of latency persists in
the 30,000 g supernatant fraction, a strong indication that this
"soluble" fraction actually contains minute, relatively buoyant
fragments of lysosomal membrane containing associated ,I3-
glucosidase activity released during homogenization and
freeze-thaw treatment. This is another indication that fibroblast
/3-glucosidase is firmly bound to the lysosomal membrane,
especially considering that other soluble lysosomal enzymes
did not exhibit any latency in the supernatant fraction. In the
case of DAP-1, the latency phase of the Triton X-100 curve
was completely absent so that the effect of the detergent on
solubilized DAP-I is purely inhibitory.
When the detergent latency characteristics of these three
enzymes in normal and DMD fibroblasts were compared, there
was no difference in the activation curves for Ga1NAcase andiß-glucosidase activities. However, there was a clear and repro-
ducible difference in the detergent activation curves for DAP-
I activity, shown in the next to the bottom, left-hand panel of
Fig. 4. To make comparison of normal and DMD groups
easier, the data are expressed as the percentage of the basal
activity when no detergent is present. The previously reported
decrease in DAP-I specific activity in DMD cells is here shown
to occur at all concentrations of Triton X-100 studied (bottom
left and right panels). The DAP-I latency curves demonstrate
that DMD fibroblasts exhibit not only a decreased total DAP-
I activity but also a significantly lower percentage of latent
DAP-I activity than normal controls. The fact that this latency
difference does not exist for the other lysosomal enzymes
indicates that this difference is specific for the components of
the DAP-I assay as opposed to a generalized leakage of en-
zymes or substrates across the lysosomal membrane of the
DMD cells. The average of the individual values for detergent
activation of the DAP-I normal and DMD cell lines (Fig. 5)
shows a difference that is statistically significant (P < 0.01).
To further determine the relationship between DAP-I and
the lysosomal membrane, we studied the release of enzymes
from the lysosomal particles by hypotonic lysis. Washed lyso-
somal pellets were incubated with hypotonic concentrations of
sucrose followed by centrifugation to separate the enzyme
activity released into the medium from the activity remaining
bound to the lysosomal particles.
The results are shown in Fig. 6. The shape of the osmotic
sedimentation curves depends markedly upon the particular
enzyme being studied, in agreement with the observations of
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FIGURE 5 Detergent activation of lysosomal DAP-1 in six normal
and eight DMD fibroblast lines. Latency is expressed as percent
stimulation of enzyme activity after addition of optimal concentra-
tion of Triton X-100. Difference between average latency for normal
cells (255%) and that for DMD cells (180%) is significant at P < 0.01 .
2
ó
r
á
w
NN
z w
0 w
z
w
w
N
z
0
z
DISCUSSION
N-ocetylgaloctosominidose
Dipeptidyl aminopeptidose I
0-glucosidase
100 200 300
[SUCROSE], mM
FIGURE 6
￿
The release of lysosomal enzymes from cultured human
fibroblast homogenates by hypotonic stress. Equal aliquots of
washed 30,000 g pellets suspended in 300 mM sucrose were diluted
with 9 vol of various sucrose solutions, producing the final sucrose
concentrations shown on the abscissa. Samples of each dilution
were assayed for enzymatic activity both before and after centrifu-
gation at 30,000 g for 20 min. The results are expressed as the
percentage of activity that remained in the supernate after centrif-
ugation (mean t SEM, n = 11). Data from dystrophic and normal
fibroblasts were combined because there was no difference be-
tween the groups.
others using lysosomes from various species and organs (24).
Thus, Ga1NAcase is representative ofone classofenzymes that
is released in approximate proportion to the hypotonicity of
the sucrose concentration. We have operationally defined such
enzymes as "soluble" lysosomal enzymes. In contrast, ß-glu-
cosidase activity is only sparingly released from the lysosomes
afterosmotic stress, and the results from this and other exper-
iments discussed above have led us to conclude that this
enzyme is firmly bound to the lysosomal particles. This agrees
with the results obtained with Iß-glucosidase from other tissues
(24). Finally, the osmotic sedimentation pattern of DAP-I
activity was found to be intermediate between those of Gal-
NAcase and ,ß-glucosidase: slight hypotonicity causes the en-
zyme to sediment as though it were bound to the particles,
whereas marked hypotonicity caused a shift to a soluble sedi-
mentation pattern. Although both normal and DMD cells were
examined for osmotic latency, the results from the DMD and
normal lysosomes are combined in Fig. 6 because no differ-
ences were seen between the groups for any of the enzymes
studied. Because the osmoprotective property of sucrose was
not different in the DMD and normal lysosomes for osmotic
sedimentation studies of three different types of enzymes, the
fragility ofthe lysosomes is apparently equivalent in DMD and
normal fibroblasts.
Lamellar bodies have been observed in a variety of conditions
related to pathological lysosomal stress. In Tay-Sachs disease,
a hereditary disorder of glycolipid metabolism with massive
cerebral accumulation of GM2 gangliosides because of the
absence ofthe lysosomal enzyme /3-D-N-acetylhexosaminidase,
there is a striking abundance of lamellar bodies (27). Similarly,
induction of intracellular ganglioside storage by feeding either
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Ngangliosides or sulfatides to cultured spinal cord or dorsal root
ganglia gives rise to lamellar body formation (30). Lamellar
bodies are also seen in I-cell diseasewhichinvolves deficiencies
in several lysosomal enzymes because of an impaired phos-
phorylation of the enzymes followed by failure to re-accumu-
late the excreted enzymes (10). Environmental or induced stress
to the lysosome is also associated with theformationof lamellar
bodies. Thus, in chloroquine myopathy there is a massive
accumulation of intralysosomal chloroquine which is thought
to increase lysosomal pH, resulting in inhibition of acid hydro-
lases and the formation of abundant lamellar bodies in the
muscle (18). The aminoglycoside antibiotics streptomycin and
gentamycin are also sequestered by lysosomes with an associ-
ated appearance of lamellar bodies in fibroblasts and kidneys
(3). Administration of other toxic compounds such as ß-3-
thienylalanine and triperanol, acholesterol synthesis inhibitor,
leads to focal cytoplasmic degradation with concomitant for-
mation of lamellar bodies (32). Increasing thepH oftheculture
medium also results in the appearance of lamellar bodies in
human fibroblasts (13). Experimental depletion of potassium
results in both muscle weakness andtheappearance oflamellar
bodies in the affected muscle (12), a situation that is thought to
mimic the inherited disorder hypokalemic periodic paralysis
(7). Certain naturally occurring conditions are also associated
with the occurrence of lamellar bodies. Thus, for example, the
type II alveolar pneumocyte which is involved in lipid secretion
normally contains lamellar and multivesicular bodies (28), and
theaginghumanskin fibroblast in cultureaccumulates lamellar
bodies as it becomes senescent (14).
Interestingly, many of these lysosomal-lamellar body con-
ditions involve specific effects on muscle tissue. Tay-Sachs
disease, chloroquine myopathy, potassium depletion, and hy-
pokalemic periodic paralysis are all associated with muscle
weakness. Lamellar bodies themselves are not all identical in
appearance, varying in size and fine structure as a function of
the cell type and the condition giving rise to their formation.
Those seen in chloroquine myopathy most closely resemble the
lamellar bodies we have observed in the fibroblasts of patients
with DMD. Wyatt and Cox (33) have also reported finding
numerous "inclusion bodies" in DMD fibroblasts, some of
which look to us quite like our lamellar bodies. Their obser-
vation has, however, been challenged by Cullen and Parsons
(5).
Morphometric analysis of the human skin fibroblasts re-
ported here has revealed a statistically significant increase in
the number of lamellar bodies present in the cytoplasm of
DMD fibroblasts. This result reinforces our earlierobservation
of a lysosomal abnormality in these DMD cells evidenced by
a marked reduction in DAP-1 (8). Analysis of the kinetic
properties of DAP-I activity in normal and DMD fibroblasts
led us to conclude that the DMD enzyme is probably not
structurally altered, but is rather present in a reduced number
ofcatalytic units. This, in turn, suggests the possibility of some
underlying lysosomal or cellular defect, a suggestion that is
strengthened by the increased presence of lamellar bodies.
However, as is clear from the preceding discussion, lamellar
bodies appear to be the common crossroad of a variety of
altered metabolic pathways and therefore do not, by them-
selves, point to a specific defect.
In the studies reported here on the further characterization
of the presumptive defect underlying the lamellar body for-
mation and the decreased DAP-1 activity, we have found a
significant decrease in thestructure-linked latencyof lysosomal
336
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 88, 1981
DAP-1 which, we believe, is evidence of an alteration in the
permeability characteristicsofDMDlysosomes. It is important
to note that the nature of this change does not appear to be a
generalized increase in the permeability of DMD lysosomal
membranes. Rather, it appears to be a selective permeability
change in which structure-linked latency is altered foronly one
of the lysosomal enzymes studied, while latency remains nor-
mal for two other lysosomal enzymes. Because the enzyme
molecules themselves are essentially membrane impermeable
and remain within the lysosomes under normal conditions, the
degree of structure-linked latency of lysosomal enzymes has
generally been attributed to the permeability characteristics of
the substrate molecules (9). Thus, a high level of substrate
permeability is associated with a relative lack of latency,
whereas an impermeable substrate will be associated with a
high degree of latency. The permeability characteristics of
essentialcofactors could also affect the latency phenomenon of
enzymatic reactions in the same manner that substrate perme-
ability does. Thus, the permeability of chloride ion or of
dithiothreitol could easily affect the degree of DAP-1 latency
because both of these are required cofactors in this enzymatic
reaction. We believe, therefore, that decreasedlysosomalDAP-
Ilatencyin DMDfibroblasts is an indication that theproperties
of the lysosomal membrane in DMD cells are altered in a
relatively specific fashion. The precise nature of this alteration
could be caused directly by an increased permeability of DMD
lysosomal membranes or indirectly by some other factor that
causes an accumulation of substrate or of one of the required
cofactors. That the decreased latency is not the result of a
unique property of the Triton X-100 detergent is shown by the
occurrence of similar latency differences with a wide variety of
other detergents (data not shown).
Because we have now described three discrete alterations in
the properties of DMD lysosomes, the question arises whether
there is a correlation between the degree of severity of one
factor and that of another. The three DMD-associated fibro-
blast abnormalities are: decreased DAP-1-specific activity, de-
creasedDAP-1 structure-linked latency, and increasedlamellar
body formation. Thus, it is possible that the decreased struc-
ture-linked latency could be a direct consequence of decreased
DAP-1 concentration. This could occur, for example, if DAP-
I were bound to the lysosomal membrane with a & similar to
the normal DAM concentration in the lysosome so that a
decrease in enzyme concentration would decrease the percent
of DAP-1 bound. If the activities of the bound and unbound
forms were different, this couldin turn give rise to an apparent
change in structure-linked latency. This possibility can be
analyzed by calculation of the correlation index, r2, which is a
measure of the degree of interdependence of these two vari-
ables. The correlation index for DAP-1 specific activity and
DAP-1 structure-linked latency in normal cells is r2 = 0.24 and
in DMD cells r2 = 0.12. Neither of these weak correlations is
statistically significant (P < 0.32 and P < 0.39, respectively).
Because the rangeofnormal DAP-1activities evaluatedis quite
broad (8), this argues strongly against the possibility that the
decreased latency in DMD cells could be caused simply by
reduced levels of the enzyme. On the other hand, if the normal
and DMD groups areconsidered as asingle set, the correlation
index increases to r2 = 0.51 with P < 0.01. This significant,
positive correlation is consistent with the presence ofacommon
underlying abnormality that affects both of these parameters.
The relationship between the appearance of lamellar bodies
and thedecrease in structure-linked latency oflysosomal DAP-I activity in DMD fibroblasts is unclearat this time. Thesetwo
parameters are only weakly associated as shown by a correla-
tion index of r2 = 0.015, and speculation as to the nature of
their relationship would be premature. However, both of these
effects appear to be related to abnormalities in the fibroblast
lysosomes, and further characterization of lysosomal function
in cultured human skin fibroblasts from DMD patients may
lead to the discovery of other phenotypic alterations in these
nonmusclecells. Such findings arepotentially applicable to the
development of methods of carrier detection and pre- and
postnatal diagnosis of DMD as well as providing potential
insight into the fundamental etiology of the disease process
itself.
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